Etelcalcetide controls secondary hyperparathyroidism and raises sclerostin levels in hemodialysis patients previously uncontrolled with cinacalcet Luciano Artur Lopes Pereira; Catarina Meng; Manuel Augusto Gonçalves Amoedo; Maria Teresa de Sousa Costa Pinto Ferreira Mendes; Marco Alexandre Mateus Prazeres Marques; João Miguel Machado Dória Frazão; André Luiz Loureiro Weigert;

Etelcalcetide: What we know eight years since its approval Pedro Freitas; Luciano Pereira;

Impact of iron chelation with deferasirox on telomere length and oxidative stress in hemodialysis patients: A randomized study Blanca Olivia Murillo Ortiz; Joel Ramírez Emiliano; Marcos Javier Romero Vázquez; Lauro Fabián Amador Medina; Sandra Martínez Garza; Edna Montserrat Ramos Rodríguez;